£120.82

Springer HIV & HTLV-I Associated Malignancies: 104 (Cancer Treatment and Research, 104)

Price data last checked 37 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£121 today · all-time low £117 (Apr 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days • 54 data points (No recent data available)

Historical
Generating forecast...
£120.85 £116.09 £117.13 £118.17 £119.20 £120.24 £121.28 10 April 2026 23 April 2026 06 May 2026 19 May 2026 02 June 2026

Price Distribution

Price distribution over 54 days • 2 price levels

Days at Price
Current Price
15 days 39 days · current 0 10 20 29 39 £117 £121 Days at Price

Price Analysis

Most common price: £121 (39 days, 72.2%)

Price range: £117 - £121

Price levels: 2 different prices over 54 days

Description

Infection with the human immunodeficiency virus (HIV) and human T-cell lymphotropic virus type I (HTLV-I) is known to be associated with an increased risk of neoplastic disorders, especially Kaposi's sarcoma and aggressive B-cell lymphoma for the former, and T-cell lymphoma for the latter. The information obtained from the study of these infections has led to remarkable advances in our understanding of the immune system, as well as the biology of human neoplasms. The management of malignant diseases in such patients also poses substantial challenges to clinicians. This book provides an overview of the epidemiology, biology, clinical features, and clinical management of neoplasms occurring in such individuals. It is an important resource for clinicians treating these diseases, and for basic scientists who have an interest in this field.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 December 2000
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Cancers in People with HIV and AIDS: Progress and Challenges
88% match

Cancers in People with HIV and AIDS: Progress and Challenges

Springer

£49.80 18 May 2026
HIV-associated Hematological Malignancies
87% match

HIV-associated Hematological Malignancies

Springer

£103.24 02 Jun 2026
Adult T-cell Leukemia/Lymphoma
85% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.03 06 Jun 2026
Molecular Basis for Therapy of AIDS-Defining Cancers
83% match

Molecular Basis for Therapy of AIDS-Defining Cancers

Springer

£107.98 24 May 2026
AIDS-Associated Syndromes: 187 (Advances in Experimental Medicine and Biology, 187)
82% match

AIDS-Associated Syndromes: 187 (Advances in Experimental Medicine and Biology, 187)

Springer

£74.27 28 May 2026
Retrovirus Infections of the Nervous System: Current and Future Perspectives: 160 (Current Topics in Microbiology and Immunology, 160)
82% match

Retrovirus Infections of the Nervous System: Current and Future Perspectives: 160 (Current Topics in Microbiology and Immunology, 160)

Springer

£74.12 21 May 2026
Cancer in Transplantation: Prevention and Treatment: Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995: 27
82% match

Cancer in Transplantation: Prevention and Treatment: Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995: 27

Springer

£76.38 25 May 2026
Human Retroviral Infections: Immunological and Therapeutic Control (Infectious Agents and Pathogenesis)
81% match

Human Retroviral Infections: Immunological and Therapeutic Control (Infectious Agents and Pathogenesis)

Springer

£129.71 22 Jun 2026
Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)
81% match

Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)

Springer

£81.58 06 Jun 2026
Immunosurveillance, Immunodeficiencies and Lymphoproliferations: Lymphoproliferative Disorders in Congenital and Acquired Immunodeficiencies: 159 (Recent Results in Cancer Research, 159)
81% match

Immunosurveillance, Immunodeficiencies and Lymphoproliferations: Lymphoproliferative Disorders in Congenital and Acquired Immunodeficiencies: 159 (Recent Results in Cancer Research, 159)

Springer

£74.06 24 May 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
80% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 06 Jun 2026
Viruses and Human Cancer
80% match

Viruses and Human Cancer

Springer

£84.59 03 Jul 2026
HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)
80% match

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Springer

£73.10 30 May 2026
Infectious Agents and Cancer
79% match

Infectious Agents and Cancer

Springer

£73.44 28 May 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
79% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 01 Jun 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
79% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 21 May 2026
Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)
79% match

Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)

Springer

£113.76 29 Jun 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
79% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 01 Jun 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
79% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 19 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
79% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
HIV Interactions with Dendritic Cells: Infection and Immunity
78% match

HIV Interactions with Dendritic Cells: Infection and Immunity

Springer

£107.98 27 May 2026
Pediatric Lymphomas (Pediatric Oncology)
78% match

Pediatric Lymphomas (Pediatric Oncology)

Springer

£95.70 05 Jun 2026
Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)
78% match

Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)

Springer

£73.85 25 May 2026
Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)
78% match

Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)

Springer

£84.28 05 Jun 2026